Cargando…

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients

Since the beginning of 2020, the whole world has been struggling with the pandemic of Coronavirus Disease 2019 (COVID-19) caused by a novel coronavirus SARS-CoV-2. The SARS-CoV-2 infection depends on ACE2, TMPRSS2, and CD147, which are expressed on host cells. Several studies suggest that some singl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sieńko, Jerzy, Kotowski, Maciej, Bogacz, Anna, Lechowicz, Kacper, Drożdżal, Sylwester, Rosik, Jakub, Sietnicki, Marek, Sieńko, Magdalena, Kotfis, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382582/ https://www.ncbi.nlm.nih.gov/pubmed/32764907 http://dx.doi.org/10.2147/CIA.S261516

Ejemplares similares

Association of ACE2 Gene Variants with the Severity of COVID-19 Disease—A Prospective Observational Study
por: Sienko, Jerzy, et al.
Publicado: (2022)

FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
por: Drożdżal, Sylwester, et al.
Publicado: (2020)

COVID-19: Pain Management in Patients with SARS-CoV-2 Infection—Molecular Mechanisms, Challenges, and Perspectives
por: Drożdżal, Sylwester, et al.
Publicado: (2020)

An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
por: Drożdżal, Sylwester, et al.
Publicado: (2021)

Kidney damage from nonsteroidal anti‐inflammatory drugs—Myth or truth? Review of selected literature
por: Drożdżal, Sylwester, et al.
Publicado: (2021)

COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
por: Lechowicz, Kacper, et al.
Publicado: (2020)

Assessment of Oxidative Stress Markers in Hypothermic Preservation of Transplanted Kidneys
por: Tejchman, Karol, et al.
Publicado: (2021)

The Role of Endothelins, IL-18, and NGAL in Kidney Hypothermic Machine Perfusion
por: Tejchman, Karol, et al.
Publicado: (2021)

Acute and Chronic Pain Learning and Teaching in Medical School—An Observational Cross-Sectional Study Regarding Preparation and Self-Confidence of Clinical and Pre-Clinical Medical Students
por: Lechowicz, Kacper, et al.
Publicado: (2019)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Lee, Ivan T., et al.
Publicado: (2020)

The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial
por: Karolak, Igor, et al.
Publicado: (2023)

Cardiac Delirium Index for Predicting the Occurrence of Postoperative Delirium in Adult Patients After Coronary Artery Bypass Grafting
por: Lechowicz, Kacper, et al.
Publicado: (2021)

Balancing intubation time with postoperative risk in cardiac surgery patients – a retrospective cohort analysis
por: Kotfis, Katarzyna, et al.
Publicado: (2018)

Controversy regarding ACE inhibitors / ARBs in COVID-19
por: Soria Arcos, Federico, et al.
Publicado: (2020)

Biomarkers and Mechanisms of Oxidative Stress—Last 20 Years of Research with an Emphasis on Kidney Damage and Renal Transplantation
por: Tejchman, Karol, et al.
Publicado: (2021)

Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation
por: Bogacz, Anna, et al.
Publicado: (2021)

Microchimerism as Post-Transplant Marker of a Chronic Rejection Process
por: Sieńko, Jerzy, et al.
Publicado: (2023)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
por: Kotfis, Katarzyna, et al.
Publicado: (2022)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
por: Kotfis, Katarzyna, et al.
Publicado: (2021)

COVID-19-related deaths not increased with ACE inhibitor or ARB use
Publicado: (2020)

The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
por: Najafi, Narges, et al.
Publicado: (2022)

What Evidence Supports Guidelines for Use of ACE Inhibitors and ARBs in Diabetes?
por: Curtiss, Frederic R.
Publicado: (2006)

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
por: Rossi, Gian Paolo, et al.
Publicado: (2020)

The concern about ACE/ARB and COVID-19: Time to hold your horses!
por: Pergolizzi, Joseph V., et al.
Publicado: (2020)

Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2
por: Emilsson, Valur, et al.
Publicado: (2020)

Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients
por: Kotowski, Maciej J., et al.
Publicado: (2019)

ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?
por: Kalyesubula, Robert, et al.
Publicado: (2014)

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
por: Braude, Philip, et al.
Publicado: (2020)

SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs
por: Ciulla, Michele M.
Publicado: (2020)

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
por: Byttebier, Geert, et al.
Publicado: (2021)

Utility of Diagnostic Imaging in the Early Detection and Management of the Fournier Gangrene
por: Sumisławski, Piotr, et al.
Publicado: (2022)

Medical Face Masks Do Not Affect Acid–Base Balance Yet Might Facilitate the Transmission of Staphylococcus aureus in Hospital Settings during the COVID-19 Pandemic
por: Ostrowski, Piotr, et al.
Publicado: (2023)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
por: Flacco, Maria Elena, et al.
Publicado: (2020)

NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
por: Annie, Frank H., et al.
Publicado: (2021)

ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008
por: Bian, Boyang, et al.
Publicado: (2010)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
por: Chung, Mina K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_05ud01c3vcj4nq9nt7col37ref